A landmark clinical trial led by Australian researchers reveals that a widely used cholesterol-lowering medication, typically prescribed for younger high-risk patients, may safely benefit otherwise healthy individuals over 70 by lowering their chances of heart attack or stroke. The study suggests these drugs carry minimal serious side effects for older adults, expanding potential preventive care for an age group where cardiovascular risks remain significant. While statins are already standard for those under 75 with conditions like diabetes or high cholesterol, the findings could prompt new considerations for broader use in healthy older populations. Experts will likely weigh the trial’s implications against existing guidelines as discussions on preventive health measures evolve.
Australian-led trial finds low risk of side effects from common cholesterol-lowering medication for otherwise healthy older peopleGet our breaking news email, free app or daily news podcastTaking a common cholesterol-lowering medication can reduce the risk of a heart attack or stroke for people aged over 70, with a low risk of serious side effects, a world-first clinical trial led by Australian researchers has found.Statins are already commonly prescribed to people under the age of 75 who meet certain risk criteria, such as having diabetes and high cholesterol, to prevent them from having a major heart event such as a heart attack, stroke, or from requiring heart surgery. Continue reading...
